(Q49068948)

18 February 2018

title

Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells. (English)

1 reference

18 February 2018

0 references

M E Stockton

1

1 reference

18 February 2018

K Rasmussen

series ordinal

2

1 reference

18 February 2018

publication date

1 March 1996

1 reference

18 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

18 February 2018

volume

124

1 reference

18 February 2018

page(s)

50-56

1 reference

18 February 2018

issue

1-2

1 reference

18 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02245605

exact match

0 references

cites work

Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area

1 reference

https://api.crossref.org/works/10.1007%2FBF02245605

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245605

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245605

Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245605

Psychosis during methylphenidate abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02245605

Clozapine-induced agranulocytosis. A genetic and epidemiologic study

21 January 2018

1 reference

12 December 2020

Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.

1 reference

12 December 2020

Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment

1 reference

12 December 2020

A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects

1 reference

12 December 2020

The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent

1 reference

12 December 2020

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

12 December 2020

The risks and benefits of clozapine versus chlorpromazine

1 reference

12 December 2020

Differential expression of autoreceptors in the ascending dopamine systems of the human brain

1 reference

12 December 2020

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

12 December 2020

Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine.

1 reference

12 December 2020

CLOZAPINE AND AGRANULOCYTOSIS

1 reference

12 December 2020

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

12 December 2020

A prospective study of clozapine in treatment-resistant schizophrenic patients. I. Preliminary report.

1 reference

12 December 2020

Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease

1 reference

12 December 2020

Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons

1 reference

12 December 2020

The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons

1 reference

12 December 2020

The effect of some psychoactive drugs on central monoamine neurons.

1 reference

12 December 2020

Paradoxical GABA excitation of nigral dopaminergic cells: Indirect mediation through reticulata inhibitory neurons

1 reference

12 December 2020

A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists

1 reference

12 December 2020

Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine (LY170053), an antipsychotic drug candidate

1 reference

12 December 2020

Clinical efficacy of serotonin-dopamine antagonists relative to classic neuroleptics

1 reference

12 December 2020

Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity

1 reference

12 December 2020

Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse

1 reference

12 December 2020

Radioreceptor binding profile of the atypical antipsychotic olanzapine.

1 reference

12 December 2020

Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs

1 reference

12 December 2020

Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha 1-adrenergic and muscarinic receptors in vivo in rats.

1 reference

12 December 2020

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

12 December 2020

Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity

1 reference

12 December 2020

Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons.

1 reference

12 December 2020

A subpopulation of mesocortical dopamine neurons possesses autoreceptors

1 reference

12 December 2020

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 reference

12 December 2020

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

12 December 2020

Seroquel: electrophysiological profile of a potential atypical antipsychotic.

1 reference

12 December 2020

Clozapine's effect on negative symptoms in treatment-refractory schizophrenics

1 reference

12 December 2020

A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons

1 reference

12 December 2020

Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity

1 reference

12 December 2020

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245605

1 reference

18 February 2018

Dimensions Publication ID

0 references

1 reference

18 February 2018